THE SOUTH AFRICAN
DEPRESSION AND ANXIETY
GROUP

facebooktwitter

Contact A Counsellor

counsellor button

KNOW MORE

panic anxiety icon

panic anxiety icon

IN THE WORKPLACE

Research on Depression in the Workplace.

For more information please click here

business

SADAG NEWSLETTER

email subscribers list

To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here

MHM JOURNAL

Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 7 Issue1 small

Click here for more info

JOURNALISTS

journalists crew making newspaper

If you are a journalist writing a story contact Cassey or Kayla or Tracy on 011 234 4837 office@anxiety.org.za

SPEAKING BOOKS

cope with cancer book

Literacy is a luxury that many of us take for granted. That is why SADAG created SPEAKING BOOKS and revolutionized the way healthcare information is delivered to low literacy communities.

The customizable 16-page book, read by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood by everyone across the world.

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 100+ titles, such as TB, Malaria, Polio, Vaccines for over 45 countries.

suicide speaking book

By Gene Emery

BOSTON (Reuters) - The drug Suboxone may help opium addicts kick their habit, but it makes little difference whether taken once or three times a week or whether patients also receive intensive counseling, a new study shows.

About 40 percent of 166 volunteers passed their urine tests in a 24-week study, regardless of which combination of counseling and Suboxone therapy they received.

Without the drug, only about 5 percent would probably have had a clean urine sample, said study leader David Fiellin in the report in this week's New England Journal of Medicine.

The findings suggest that aggressive counseling may be unnecessary for opium addicts who take the small orange tablet, which relieves symptoms of opiate withdrawal such as agitation, nausea and insomnia.

The study shows that "patients can receive this medication and do well in a primary care physician's office" with nothing more than weekly counseling, Fiellin, of the Yale University School of Medicine in New Haven, Conn., told Reuters.

Suboxone, made by the healthcare unit of Britain's Reckitt Benckiser Plc, is available by prescription at any pharmacy and is aimed at getting drug addiction patients away from poorly run clinics.

It contains buprenorphine, a narcotic that produces less euphoria than morphine, codeine or heroin. It also contains naloxone, another drug that interferes with the effects of opioids on the brain.

"We were surprised but somewhat pleased to see that patients did as well with the medication and briefer counseling," said Fiellin. The next step is to see if the counseling is only needed once a month, he added.

 

Our Sponsors

Our Partners